Open original FDA record ↗Recall record
- FDA identifier
- Z-0132-2026
- Company in FDA record
- Insulet Corporation
- FDA classification date
- Oct 10, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying feature of the iPhone, while simultaneously selecting a single number on the keyboard. This causes the single digit number to duplicate. This could result in errors in manual entry of digits - examples: bolus entry, I:C ratio, bolus calculator, prior to starting the bolus insulin delivery. Therefore, this may result in over delivery of insulin which may cause hypoglycemia.
Source facts
- Action
- Insulet notified both healthcare professionals and users on about 09/11/2025 via URGENT: Medical Device Correction letter. Instructions included that an update to the application will be pushed to all devices and should be implemented by users. Users were also requested to confirm receipt and acknowledgement of the notification but selecting the "acknowledgement button" in the email.
- Initiated
- 2025-09-11
- Root cause
- Software design
- Distribution
- US Nationwide distribution.
- Recall number
- Z-0132-2026
- Recall status
- Open, Classified
- CDRH record ID
- 216042
- FDA classified
- 2025-10-10
- Recall event number
- 97597